High-risk human papillomavirus testing versus cytology in predicting post-treatment disease in women treated for high-grade cervical disease: a systematic review and meta-analysis.
about
Follow-up strategies after treatment (large loop excision of the transformation zone (LLETZ)) for cervical intraepithelial neoplasia (CIN): Impact of human papillomavirus (HPV) testHPV-Testing in Follow-up of Patients Treated for CIN2+ LesionsClinical progression of high-grade cervical intraepithelial neoplasia: estimating the time to preclinical cervical cancer from doubly censored national registry data.Human papillomavirus community in healthy persons, defined by metagenomics analysis of human microbiome project shotgun sequencing data setsResidual disease and HPV persistence after cryotherapy for cervical intraepithelial neoplasia grade 2/3 in HIV-positive women in Kenya.Clinical significance of HPV-DNA testing for precancerous cervical lesionsLong-Term Clinical Outcome after Treatment for High-Grade Cervical Lesions: A Retrospective Monoinstitutional Cohort StudyPosttreatment human papillomavirus testing for residual or recurrent high-grade cervical intraepithelial neoplasia: a pooled analysis.Stratification of HPV-induced cervical pathology using the virally encoded molecular marker E4 in combination with p16 or MCMThe incidence of human papillomavirus infection following treatment for cervical neoplasia: a systematic review.Five-year risk of recurrence after treatment of CIN 2, CIN 3, or AIS: performance of HPV and Pap cotesting in posttreatment management.Human Papilloma Virus Persistence after Cone Excision in Women with Cervical High Grade Squamous Intraepithelial Lesion: A Prospective Study.The Clinical Role of HPV Testing in Primary and Secondary Cervical Cancer Screening.Significant association between CYP1A1 T3801C polymorphism and cervical neoplasia risk: a systematic review and meta-analysis.Follow up with HPV test and cytology as test of cure, 6 months after conization, is reliable.Good performance of p16/ki-67 dual-stained cytology for surveillance of women treated for high-grade CIN.Long-term follow-up of the risk for cervical intraepithelial neoplasia grade 2 or worse in HPV-negative women after conization.Human papillomavirus type-specific persistence and reappearance after successful conization in patients with cervical intraepithelial neoplasia.Long-term costs of introducing HPV-DNA post-treatment surveillance to national cervical cancer screening in Ireland.Role of human papillomavirus testing and cytology in follow-up after conization.Human papillomavirus type-specific persistence and recurrence after treatment for cervical dysplasia.Development of a goat model for evaluation of withaferin A: Cervical implants for the treatment of cervical intraepithelial neoplasia.Arguments in favor of HPV testing for cervical screening and post-treatment CIN2+ monitoring.Is self-sampling to test for high-risk papillomavirus an acceptable option among women who have been treated for high-grade cervical intraepithelial neoplasia?Implications of Post-LLETZ “Treatment Failure” for Further Management of HIV-Infected Women
P2860
Q24186721-C0335898-7D8E-4734-BB33-501330DEF7B2Q26771420-C86570F7-28CC-47DD-9995-ABF082751C5AQ30658080-A3D69443-199E-4383-A1AA-D785197FA2E9Q30756107-9176C383-646B-4B94-B76C-98ADD9B883DFQ34400805-3084B23F-2AF7-4C78-9176-5242FF4EB542Q35340725-754330B6-55F6-4D1A-8D27-3F47950E22D3Q35768850-D49AC8D7-8E7E-45A3-AEDB-0E0930AEAE7AQ35805474-72575192-43B2-466D-B374-539B5334DB04Q35811067-E49B5126-2C9C-4953-A739-2735DCD7E263Q35984769-56A9800A-0FBF-46E8-BCDE-8CC4BC7DC0E4Q36739942-CC7856FE-C010-4EC8-8DD8-BADB2A747D8DQ36996829-910F1D53-50B8-4E68-A0D3-386010587CA3Q37018994-0D8FE573-43F7-427E-A8D0-978D466C9BDEQ38051275-B63989A9-9905-4C9A-989D-1C0537C853D0Q40500436-F76D2008-1640-44DC-A1D8-92F1C579DD5DQ40525853-BED508E1-7BD0-4402-84B2-C71071C321B1Q40771931-DB1043A4-ADA4-4732-A8AF-4230E13A7531Q40892020-2C6CF60B-0740-4A46-AD4B-E347D6A19A1BQ40995859-37B7F537-EC9D-4BFE-8FEE-93D823CF6A68Q41489942-68E8E42E-B6C1-4C82-AD47-46FA6C4A8D86Q42262648-42F074DC-9117-499A-B22B-EF7E14E9FB2DQ47574958-32C80587-7BA8-425B-95A3-17B728BB3816Q51847800-3BF3642D-85E7-4294-99D4-B464393578F0Q55303411-EC64F109-1367-47C5-B296-E672A25EFFB4Q59049573-17DFFEB0-7432-463D-A158-AF706542E159
P2860
High-risk human papillomavirus testing versus cytology in predicting post-treatment disease in women treated for high-grade cervical disease: a systematic review and meta-analysis.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
High-risk human papillomavirus ...... atic review and meta-analysis.
@ast
High-risk human papillomavirus ...... atic review and meta-analysis.
@en
High-risk human papillomavirus ...... atic review and meta-analysis.
@nl
type
label
High-risk human papillomavirus ...... atic review and meta-analysis.
@ast
High-risk human papillomavirus ...... atic review and meta-analysis.
@en
High-risk human papillomavirus ...... atic review and meta-analysis.
@nl
prefLabel
High-risk human papillomavirus ...... atic review and meta-analysis.
@ast
High-risk human papillomavirus ...... atic review and meta-analysis.
@en
High-risk human papillomavirus ...... atic review and meta-analysis.
@nl
P2093
P1433
P1476
High-risk human papillomavirus ...... atic review and meta-analysis.
@en
P2093
Anton L M de Vries
Chris J L M Meijer
Johannes Berkhof
Johannes C F Ket
Margot H Uijterwaal
Mariëlle Kocken
Theo J M Helmerhorst
P304
P356
10.1016/J.YGYNO.2012.01.015
P407
P577
2012-01-18T00:00:00Z